← All research

Training on a GLP-1: 10 Questions About Muscle, Cardio and Energy

Last verified May 2026 · 10 questions · 8 PubMed citations

Questions taken from r/Zepbound, r/Wegovy, r/Semaglutide, r/Mounjaro, r/Ozempic

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

The body-composition question is the one that actually matters here, and it has a real answer rather than a motivational one. ★ Where a number comes from a scan substudy rather than a scale, we say so, because the two tell different stories — the scale can sit still while the composition underneath it improves. ⚠ Several answers concern how a week on a weekly injection is not uniform: intake, energy and side effects all move on a predictable cycle, and training plans that ignore that cycle fail for reasons people blame on themselves. ⛔ Older readers should note the strength findings specifically, where the functional decline can run ahead of what a scan predicts.

Questions and answers

Q1.Does lifting actually protect my muscle?

★ Yes, and this is the one question here with a properly controlled answer. S-LITE, a one-year Danish trial, ran four arms after an eight-week low-calorie diet: liraglutide alone, supervised exercise alone, both, and placebo. The combined arm lost the most fat while keeping the most lean tissue, and its ratio of lean to fat loss beat the drug-only group clearly. ⚠ Drug alone worked — it just took a meaningfully bigger share of that loss out of muscle. ★ For scale on what happens without structured training: STEP-1 saw roughly 39% of total weight loss come from lean tissue against 61% fat, and the SURMOUNT-1 scan substudy recorded about 33.9% fat-mass loss against 10.9% lean at the top dose, so the proportion of the body that was fat still fell. ⛔ Two or three sessions a week is the intervention. It is not optional if muscle matters to you.

Source thread ↗PMID 33951361PMID 39996356PMID 33567185

Q2.Why is cardio so much harder now?

★ Two reasons, and neither means your fitness has gone backwards. First, fuel: intake commonly falls by a third or more during titration, so glycogen is lower and the same session has less to run on. ⚠ Second, heart rate. A rise of a few beats per minute at a given workload is a documented class effect, which means an identical pace genuinely registers as harder effort even when nothing about your actual capacity has changed. ★ The fitness data support that reading — a systematic review of weight-lowering drugs found modest gains in walking capacity and self-reported function, while the peak-capacity signal was variable and trial-dependent. ⛔ Dehydration on titration days makes all of it worse and is the easiest thing to fix. ★ The reported pattern matches the trials: hardest in the first few weeks of each dose step, normalizing once intake and hydration catch up.

Source thread ↗PMID 33567185PMID 36721366

Q3.Can I actually gain muscle while losing weight?

⚠ Difficult, and the honest answer depends heavily on where you are starting. Even the best trial result was lean-mass PRESERVATION rather than net gain for most participants. ★ Two things work against you: gaining muscle in a substantial calorie deficit is uncommon in already-trained people, and a retrospective analysis found that carrying obesity and metabolic disease dulls how well muscle answers protein and training — so the usual stimulus is simply less efficient in this population, before any drug is involved. ★ Where it does happen is predictable: someone previously detrained, returning to basic compound lifts, has room for genuine recomposition. Almost every convincing forum report fits that description. ⛔ Do not let the framing mislead you though — the scan data show fat loss dwarfing lean loss in absolute terms, so your body-fat percentage falls either way. Preservation is the realistic goal and it is a good one.

Source thread ↗PMID 33951361PMID 39771028PMID 39996356

Q4.How much protein do I actually need?

★ Somewhere between 1.2 and 1.6 grams for each kilogram you weigh, every day, split across three or four feedings, toward the top of that range on lifting days. That is where trial protocols and obesity-pharmacotherapy reviews converge. ⚠ Worth knowing why it matters so much here: the pivotal trials did NOT impose a high-protein diet. They paired the drug with a 500-calorie deficit and standard counseling — and the lean-mass losses they recorded reflect that. The S-LITE arms that did best on body composition had structured training and standardized intake. ⛔ The practical obstacle is not knowledge, it is appetite. Hitting that target requires deliberate planning once the same volume of food feels like a large meal, and it will not happen by eating intuitively. ★ Thirty to forty grams per meal is the pattern people settle on, with a larger feeding after training.

Source thread ↗PMID 38710803PMID 33567185PMID 39996356PMID 33951361

Q5.Why do I have nothing in the tank after my shot?

★ Because the injection week is not uniform, and the first days are the trough. Intake drops sharply in the first 24 to 72 hours after each dose as gastric emptying slows and appetite suppression peaks — trial participants consistently described that window as the strongest reduction in food preoccupation. ⚠ Less carbohydrate in those days means less muscle glycogen and a harder time with anything high-intensity. ★ Separately, the fitness meta-analysis found modest gains in walking capacity but no consistent early improvement in peak exercise capacity; the cardiorespiratory benefits arrive later, as weight comes off. ★ The adjustment people make is simple and effective: put strength work on days three to six after the injection rather than days one and two, once intake has recovered. ⛔ Expect the effect to be sharpest in the week of any dose increase, when stomach symptoms peak at the same time.

Source thread ↗PMID 33567185PMID 36721366

Q6.Should I plan training around my injection day?

★ It helps, though no trial randomized anyone to test it, so this is reasoning from the side-effect curve rather than from a result. What the trials establish is that GI symptoms and reduced intake peak in the first one to three days after an injection and taper across the week. ⚠ So the sensible alignment is light work — mobility, easy cardio, recovery — in days one and two, with heavier resistance or interval sessions in days four to seven. ⛔ Do not overrate single-session timing though. The scan data indicate your fat-to-lean ratio is driven by protein intake and training stimulus accumulated over weeks, not by which day you lifted. ⚠ One group should take this more seriously: a 2026 review on these drugs and muscle strength found that older people can shed a disproportionate amount of strength while weight is coming off fast, and advised pacing hard sessions around the injection cycle deliberately.

Source thread ↗PMID 33567185PMID 39996356PMID 41577337

Q7.Is my higher heart rate on cardio a problem?

★ Usually not — a resting rise of two to five beats per minute is a documented class effect, and it is among the very few cardiovascular measures that drift unfavorably while blood pressure, lipids and inflammatory markers all improve. The mechanism is not fully established, and appears to involve autonomic modulation. ⚠ In practice that means the same run at the same pace can read five to ten beats higher than your pre-drug baseline, which is disconcerting without being dangerous. The fitness meta-analysis confirmed the heart-rate-at-workload pattern while finding no signal that exercise capacity or safety suffered at maintenance doses. ⛔ What is NOT this: a sudden jump of thirty or more beats above what you would expect, chest pain, fainting, or palpitations on light exertion. Those need a clinician regardless of what drug you are on, and should not be filed under expected side effects.

Source thread ↗PMID 33567185PMID 35658024PMID 36721366

Q8.Will I lose my running endurance?

★ Endurance holds up better than any other fitness domain here, and often improves. The systematic review found these drugs modestly increase six-minute walk distance and self-reported physical function, and STEP-1 recorded better self-reported physical functioning at week 68 alongside its 14.9% weight loss. ⚠ There is also plain physics: less weight at the same absolute pace is a lower relative effort. The commonly described arc is slower paces through titration weeks, then faster paces by months six to nine once 10-15% is gone. ⛔ The catch is fuel, and it bites hardest at distance. Chronic underfueling degrades long-run performance even while your 5k pace improves, because appetite suppression makes it genuinely easy to under-eat on long-run days without noticing. ★ Marathon training on one of these needs a deliberate carbohydrate plan, and is worth discussing with a sports-medicine clinician rather than improvising.

Source thread ↗PMID 36721366PMID 33567185

Q9.What does it mean if I get dizzy training?

⚠ Three reversible causes account for most of it, and one deserves separate attention. Dehydration is the commonest — slowed emptying plus reduced drinking, and the trial safety tables record dehydration-related events noticeably more often on drug than on placebo. Low blood sugar is next, and mainly concerns anyone whose regimen also includes insulin or a sulfonylurea rather than these drugs by themselves. Third, blood-pressure changes on standing after rapid weight loss. ★ The fixes match: get fluids and electrolytes in early on training days, eat something 30 to 60 minutes beforehand, and ease off the intensity during the first week on any new dose. ⛔ The one that is not simply reversible: the 2026 strength review warned that losing lean tissue quickly can leave older people less steady on their feet and more prone to falls. ⛔ And persistent dizziness, fainting, chest pain or palpitations are clinician signals regardless of the drug.

Source thread ↗PMID 33567185PMID 35658024PMID 41577337

Q10.If I never train, do I lose all my muscle?

⛔ Not all of it — though lean tissue will account for a real slice of whatever comes off, and the trials are consistent about that. STEP-1 recorded roughly 39% of total loss as lean and 61% as fat, in participants with no structured training program. The SURMOUNT-1 scan substudy found about 33.9% fat-mass loss against 10.9% lean over 72 weeks, again with no training arm. ★ S-LITE is the trial that answers the actual question, because it contrasted exercise against no exercise directly, and lean-mass preservation was meaningfully better with structured training. ⚠ A 2026 review in older adults adds an uncomfortable detail: measured strength can fall further than the lean-mass figures would lead you to expect, so function can slip faster than a scan reveals. ★ The encouraging part is how little it takes — two sessions a week already leaves you in far better shape than none.

Source thread ↗PMID 33567185PMID 39996356PMID 33951361PMID 41577337

References

  1. 1.Lundgren JR, Janus C, Jensen SBK, et al Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined N Engl J Med. 2021. PMID: 33951361.
  2. 2.Wilding JPH, Batterham RL, Calanna S, et al Once-Weekly Semaglutide in Adults with Overweight or Obesity N Engl J Med. 2021. PMID: 33567185.
  3. 3.Jastreboff AM, Aronne LJ, Ahmad NN, et al Tirzepatide Once Weekly for the Treatment of Obesity N Engl J Med. 2022. PMID: 35658024.
  4. 4.Look M, Dunn JP, Kushner RF, et al Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight Diabetes Obes Metab. 2025. PMID: 39996356.
  5. 5.Jobanputra R, Sargeant JA, Almaqhawi A, et al The effects of weight-lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta-analysis of randomized controlled trials Obes Rev. 2023. PMID: 36721366.
  6. 6.Henney AE, Wilding JPH, Alam U, Cuthbertson DJ Obesity pharmacotherapy in older adults: a narrative review of evidence Int J Obes (Lond). 2025. PMID: 38710803.
  7. 7.Nilsson MI, Xhuti D, de Maat NM, et al Obesity and Metabolic Disease Impair the Anabolic Response to Protein Supplementation and Resistance Exercise: A Retrospective Analysis of a Randomized Clinical Trial with Implications for Aging, Sarcopenic Obesity, and Weight Management Nutrients. 2024. PMID: 39771028.
  8. 8.Prokopidis K Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults: Risks beyond muscle mass reductions Br J Pharmacol. 2026. PMID: 41577337.

Questions are paraphrased from public forum threads and linked to their source where one was recorded. Answers summarize published trial data and FDA labeling. This is not medical advice, and no part of it replaces the judgment of whoever prescribes for you.